These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10160470)

  • 61. Prevalence of migraine and response to sumatriptan in patients self-reporting tension/stress headache.
    Kaniecki R; Ruoff G; Smith T; Barrett PS; Ames MH; Byrd S; Kori S
    Curr Med Res Opin; 2006 Aug; 22(8):1535-44. PubMed ID: 16870078
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prospective large-scale study of the tolerability of subcutaneous sumatriptan injection for acute treatment of migraine.
    O'Quinn S; Davis RL; Gutterman DL; Pait GD; Fox AW
    Cephalalgia; 1999 May; 19(4):223-31; discussion 200. PubMed ID: 10376167
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Meeting acute migraine treatment needs through novel treatment formulations.
    Silberstein SD
    Neurotherapeutics; 2010 Apr; 7(2):153-8. PubMed ID: 20430313
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Dihydroergotamine: a review of its use in the treatment of migraine and other headaches.
    Scott AK
    Clin Neuropharmacol; 1992 Aug; 15(4):289-96. PubMed ID: 1516074
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Sumatriptan nasal spray for migraine: a review of studies in patients aged 17 years and younger.
    Hämäläinen M; Jones M; Loftus J; Saiers J
    Int J Clin Pract; 2002 Nov; 56(9):704-9. PubMed ID: 12469987
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Dihydroergotamine nasal spray in the treatment of acute migraine.
    Treves TA; Kuritzky A; Hering R; Korczyn AD
    Headache; 1998 Sep; 38(8):614-7. PubMed ID: 11398305
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of subcutaneous sumatriptan with usual acute treatments for migraine. French Sumatriptan Study Group.
    Boureau F; Chazot G; Emile J; Bertin L; d'Allens H
    Eur Neurol; 1995; 35(5):264-9. PubMed ID: 8542914
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Renal papillary necrosis following emergency department treatment of migraine.
    Witting MD
    J Emerg Med; 1996; 14(3):373-6. PubMed ID: 8782036
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Sumatriptan nasal spray 20mg: efficacy, tolerance and quality of life in migraine patients].
    Géraud G; Valette C
    Rev Neurol (Paris); 2000 Jul; 156(6-7):646-53. PubMed ID: 10891800
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Impact of sumatriptan on clinic utilization and costs of care in migraineurs.
    Litaker DG; Solomon GD; Genzen JR
    Headache; 1996 Oct; 36(9):538-41. PubMed ID: 8916561
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Status migrainosus].
    Alberca R; Casado JL; Arenas C; Moreno A; Serrano V
    Rev Neurol; 1995; 23 Suppl 2():S208-11. PubMed ID: 7497290
    [No Abstract]   [Full Text] [Related]  

  • 72. Does the presence of aura inform us regarding migraine severity and response to treatment?
    Ward TN
    Neurology; 2015 May; 84(18):1828-9. PubMed ID: 25841027
    [No Abstract]   [Full Text] [Related]  

  • 73. [The treatment of migraine].
    Titus F
    Rev Neurol; 1997 Feb; 25(138):295-300. PubMed ID: 9147762
    [No Abstract]   [Full Text] [Related]  

  • 74. Treatment with sumatriptan 50 mg in the mild phase of migraine attacks in patients with infrequent attacks: a randomised, double-blind, placebo-controlled study.
    Tfelt-Hansen P; Bach FW; Daugaard D; Tsiropoulos I; Riddersholm B
    J Headache Pain; 2006 Dec; 7(6):389-94. PubMed ID: 17164991
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dihydroergotamine (DHE) - Then and Now: A Narrative Review.
    Silberstein SD; Shrewsbury SB; Hoekman J
    Headache; 2020 Jan; 60(1):40-57. PubMed ID: 31737909
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dihydroergotamine mesylate nasal spray: an acute treatment option for migraine in adults.
    Silvestro M; Orologio I; Tessitore A; Trojsi F; Tedeschi G; Russo A
    Expert Rev Neurother; 2024 Jun; 24(6):555-564. PubMed ID: 38655598
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Home administration of intramuscular DHE for the treatment of acute migraine headache.
    Weisz MA; el-Raheb M; Blumenthal HJ
    Headache; 1994 Jun; 34(6):371-3. PubMed ID: 7928318
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical experience with patient administered subcutaneous dihydroergotamine mesylate in refractory headaches.
    Klapper JA; Stanton J
    Headache; 1992 Jan; 32(1):21-3. PubMed ID: 1372884
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Complicated migraine and migraine variants.
    Rothner AD
    Semin Pediatr Neurol; 2001 Mar; 8(1):7-12. PubMed ID: 11332867
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Treatment of childhood headache with dihydroergotamine mesylate.
    Linder SL
    Headache; 1994; 34(10):578-80. PubMed ID: 7843951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.